BioSpace News Archive

Cerebral Therapeutics, Inc., a clinical-stage pharmaceutical company developing innovative treatments for neurological diseases, today announced that the first patient has been enrolled in a Phase 2b study of intracerebroventricular drug delivery of the anti-seizure medication CT-010 in patients with medically refractory epilepsy. T

Veracyte (Nasdaq: VCYT) today announced a new general manager-based structure to advance the company’s growing roster of genomic tests and its global expansion. John Hanna, currently chief commercial officer, will become GM, endocrinology, breast cancer and lymphoma. The company

Bristol Myers Squibb (NYSE:BMY) announced today that it has successfully completed its acquisition of MyoKardia, Inc. in an all cash transaction for approximately $13.1 billion. With the completion of the acquisition, MyoKardia shares have ceased trading on the NASDAQ Global Select Market and MyoKardia is now a wholly-owned subsidiary of Bristol Myers Squibb. “We are excited to welcome MyoKardia colleagues to Bristol Mye

OmniPathology launches its school COVID PCR testing program, OmniClassroom.

Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the appointment of Larry A. Pickett, Jr. as Chief Information & Digital Officer.

Six of the most well-known, respected, and long-established orthopedic group practices in Texas have announced their launch as OrthoLoneStar, a single combined group practice in 2021.

Sapience Therapeutics, Inc., a clinical stage biotechnology company focused on the discovery and development of peptide therapeutics to address difficult to treat oncology indications, announced today that it has raised $14 million in its preferred stock financing. Sapience issued shares of its convertible preferred stock in this financing. The net proceeds from the preferred stock f

MedLite ID is very pleased to announce healthcare sales veteran, Bruce Thompson, joins the firm as Vice President of Sales.

Healthmap Solutions, Inc., an industry-leading Kidney Health Management company, announced it has earned Population Health Program Accreditation from the National Committee for Quality Assurance.

AllMed Healthcare Management, Inc., a leading provider of utilization management (UM) and independent review (IRO) services, today announced that Jeff Keating has joined its executive leadership team as Chief Technology Officer (CTO).